Tag Archives: Recovery

TipRanks These 2 Penny Stocks Could Rally All the Way to $11, Say Analysts At its January FOMC meeting, the Federal Reserve held interest rates steady – they are near rock-bottom now, and to no one’s surprise, the Fed is keeping them there. Fed Chairman Jerome Powell may have fed some market pessimism when he spoke after the meeting, and pointed out that unemployment, which has been rising in recent months. For market watchers seeking support, there is solace in the Fed’s monetary… Source link

The innovation that turned Google and Facebook into money-making behemoths wasn’t search or social networking. It was selling advertising space alongside content they got for free. Now, as regulatory investigations in the US, Europe and beyond raise the prospect of breaking up the companies, they’re tweaking that formula. The two firms are striking deals to start paying one important source of that content: news organizations. Not only does this help bring them in line with new… Source link

TipRanks 3 Stocks Flashing Signs of Strong Insider Buying Sometimes, following a leader makes the best investment strategy. And corporate insiders have long been popular leaders to follow. Their combination of responsibility to their stockholders and access to ‘under the hood’ information on their companies gives their personal investment choices an air of authority.The most important thing about these insiders is that whatever else they do, they are expected to shepherd their companies to… Source link

TipRanks Billionaire Ray Dalio Picks Up These 3 “Strong Buy” Stocks Sometimes, the experts will tell us what we already know. Ray Dalio, the founder of Bridgewater Associates, has built a legendary reputation in financial circles, for taking his firm from a home business in his two-bedroom apartment to the international hedge fund giant, employing over 1,500 people and managing more than $138 billion in total assets. But when questioned on how he did it, or how today’s investors can… Source link

TipRanks 3 “Strong Buy” Stocks That Tick all the Boxes It’s been said that gridlock is a feature, not a bug, of the US Constitution, and we may be about to find that out. The election results have left some questions to be resolved, but a few things are coming clear: Democrat Joe Biden is the winner of the Presidential race, but down ballot, the Republicans appear to have made important gains. We’re looking at the prospect of divided government – a Biden Administration with a… Source link

AMC (AMC) and other entertainment stocks surged on Monday in the wake of Pfizer (PFE) and BioNTech (BNTX) announcing positive news about their leading COVID-19 vaccine candidate, which demonstrated a high level of efficacy in testing. Even as the U.S. topped 10 million coronavirus cases, markets — which for months have been pricing in hopes of an end to the crisis — skyrocketed on the news. The Dow (^DJI) and S&P 500 (^GSPC) both opened at record highs, tempering those gains slightly by… Source link

TipRanks 3 High-Yield Dividend Stocks Offering at Least 8%; Analysts Say ‘Buy’ America goes to the polls on Tuesday (well, actually, America has been early voting for a few weeks, now), and while Democrat Joe Biden has a solid lead in the polls, there is some of evidence that President Trump may still win a second term. Finally, with all of the early voting, mass absentee ballots, and possible extended counting deadlines, we might not know on Tuesday night who the winner is.It’s a… Source link

GlobeNewswire COVID-19 Diagnostics Market Worth USD 8.04 Billion with Rise at 2.7% CAGR till 2027; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™ Key Prominent Players Covered in the COVID-19 Diagnostics Market Research Report Are PerkinElmer Inc., Quest Diagnostics Incorporated, Quidel Corporation, Siemens Healthcare GmbH, Abbott, Thermo Fisher Scientific Inc., bioMérieux SA, F. Hoffmann-La Roche Ltd, Danaher Corporation and… Source link

GlobeNewswire Orphan Drugs Market to Reach USD 340.84 Billion with 10.5% CAGR by 2027; Increasing Number of Regulatory Approvals will Contribute to Market Growth, says Fortune Business Insights™ Key Prominent Players Covered in the Orphan Drugs Market Research Report Are Amgen Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Alexion Pharmaceuticals Inc., Novo Nordisk A/S, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca, DAIICHI SANKYO COMPANY, LIMITED, GlaxoSmithKline plc and other key market… Source link